ArticleInternational journal of molecular sciences2019

MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells.

Eun-Ae Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.